| Ytd | 90.67% | |
| 1y | 55.68% |
| Open | 10.01 | Prev Close | 8.80 | Low | 8.79 | High | 10.34 | Mkt Cap | 410.68M |
| Vol | 0.00 | Avg Vol | 294.72K | EPS | -0.60 | P/E | -16.68 | Forward P/E | -1.78 |
| Beta | 0.98 | Short Ratio | 3.57 | Inst. Own | 69.75% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 8.20 | 200-d Avg | 6.98 | 1yr Est | 5.67 |
908 Devices Inc. (MASS) Q2 2026 Earnings Call Transcript
Gainers Quantum (NASDAQ:QMCO) stock rose 56.7% to $18.45 during Tuesday's regular session. The
908 Devices NASDAQ: MASS reported second-quarter revenue growth of 23% as demand from U.S. state and
908 Devices Inc. (MASS) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus
908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld c
908 Devices (NASDAQ:MASS) raises FY2026 sales outlook from $67.000 million-$70.000 million to $68.00
908 Devices (NASDAQ:MASS) reported quarterly losses of $(0.32) per share which missed the analyst co
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company
908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely ear
Top Wall Street analysts changed outlook on top names. Analyst rating changes include upgrades, down
908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld c
Roth Capital analyst Max Masucci initiates coverage on 908 Devices (NASDAQ:MASS) with a Buy ratin
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company
Vancouver, British Columbia--(Newsfile Corp. - July 15, 2026) - Masivo Silver Corp. (TSXV: MASS) (OT
Supporting Canada's Arctic sovereignty and maritime security through integrated, mission-ready aeros
908 Devices (MASS) might move higher on growing optimism about its earnings prospects, which is refl
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company
908 Devices (MASS) delivered strong Q1 results, raising full-year revenue guidance after a strategic
908 Devices Inc. (MASS) Q1 2026 Earnings Call Transcript
908 Devices Inc. (MASS) came out with a quarterly loss of $0.15 per share in line with the Zacks Con
908 Devices (NASDAQ:MASS) raises FY2026 sales outlook from $64.500 million-$67.500 million to $67.00
908 Devices (NASDAQ:MASS) reported quarterly losses of $(0.32) per share which missed the analyst co
BURLINGTON, Mass.--(BUSINESS WIRE)-- #ChemicalID--908 Devices Inc. (Nasdaq: MASS), a core small-cap
This acquisition expands 908 Devices' analytical portfolio and strengthens its leadership in nar
BURLINGTON, Mass.--(BUSINESS WIRE)-- #LawEnforcement--908 Devices Inc. (Nasdaq: MASS), a pioneer of
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built hand
Vancouver, British Columbia--(Newsfile Corp. - April 8, 2026) - Masivo Silver Corp. (TSXV: MASS) (OT
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
On Monday, 198 companies hit new 52-week lows.
Companies Reporting Before The Bell • Cohen & Co (AMEX:COHN) is likely to report earnings for i
OnFriday, 143 stocks hit new 52-week lows.
Monday saw 196 companies set new 52-week lows.
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly
Gainers
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor